Su H. Kang
Daegu, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Immune-Related Adverse Events in Breast Cancer Patients Who Received Neoadjuvant Chemotherapy with Pembrolizumab: What Needs to Be Managed Before Surgery.
Journal: Cancers
Published: February 06, 2026
The clinical value of clinical treatment score post-5 years in patients with premenopausal breast cancer: a retrospective analysis of ASTRRA trial.
Journal: Breast (Edinburgh, Scotland)
Published: December 10, 2025
Correction: Comparative study on bone mineral density in premenopausal patients with estrogen receptor-positive breast cancer in ASTRRA Study: a 5-year follow-up study.
Journal: Frontiers in oncology
Published: October 21, 2025
Prospective Single-Arm Study of Endocrine Therapies With Ovarian Function Suppression in Premenopausal Node-Positive Early Breast Cancer Patients With Low Genomic Risk (INTERSTELLAR Trial, KBCSG-25).
Journal: Journal of breast cancer
Published: August 01, 2025
Comparative study on bone mineral density in premenopausal patients with estrogen receptor-positive breast cancer in ASTRRA Study: a 5-year follow-up study.
Journal: Frontiers in oncology
Published: July 16, 2024
Prediction of menstrual recovery patterns in premenopausal women with breast cancer taking tamoxifen after chemotherapy: an ASTRRA Substudy.
Journal: Breast cancer research : BCR
Published: September 18, 2023
Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone Receptor-Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the ASTRRA Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 22, 2023
An observational, prospective, open label, multicenter study to evaluate the safety and effectiveness of pegfilgrastim as secondary prophylaxis to decrease the incidence of febrile neutropenia in Korean female patients with breast cancer.
Journal: Breast (Edinburgh, Scotland)
Published: August 02, 2023
Breast density reduction as a predictor for prognosis in premenopausal women with estrogen receptor-positive breast cancer: an exploratory analysis of the updated ASTRRA study.
Journal: International journal of surgery (London, England)
Published: July 05, 2023
Prediction of Oncotype DX Recurrence Score Using Clinicopathological Variables in Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.
Journal: Journal of breast cancer
Published: October 27, 2022
Risk factors for level V metastasis in patients with N1b papillary thyroid cancer.
Journal: World journal of surgical oncology
Published: May 25, 2022
Last Updated: 09/26/2026